BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21318590)

  • 1. Association between proton pump inhibitor use and anemia: a retrospective cohort study.
    Sarzynski E; Puttarajappa C; Xie Y; Grover M; Laird-Fick H
    Dig Dis Sci; 2011 Aug; 56(8):2349-53. PubMed ID: 21318590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term proton pump inhibitor therapy on hemoglobin and serum iron levels after sleeve gastrectomy.
    Sharma N; Chau WY; Dobruskin L
    Surg Obes Relat Dis; 2019 Oct; 15(10):1682-1689. PubMed ID: 31422079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.
    Tran-Duy A; Connell NJ; Vanmolkot FH; Souverein PC; de Wit NJ; Stehouwer CDA; Hoes AW; de Vries F; de Boer A
    J Intern Med; 2019 Feb; 285(2):205-214. PubMed ID: 30141278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proton pump inhibitors is associated with anemia in cardiovascular outpatients.
    Shikata T; Sasaki N; Ueda M; Kimura T; Itohara K; Sugahara M; Fukui M; Manabe E; Masuyama T; Tsujino T
    Circ J; 2015; 79(1):193-200. PubMed ID: 25392070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cytopenia in geriatric inpatients.
    Röhrig G; Becker I; Pappas K; Polidori MC; Schulz RJ
    Z Gerontol Geriatr; 2018 Feb; 51(2):231-236. PubMed ID: 28660533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-deficiency anemia caused by a proton pump inhibitor.
    Hashimoto R; Matsuda T; Chonan A
    Intern Med; 2014; 53(20):2297-9. PubMed ID: 25318791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitor Use and Iron Deficiency Anemia in Celiac Patients.
    Hawkins S; Nighot M; Dalessio S; Zhu J; Morris N; Clarke K
    Dig Dis; 2024; 42(1):25-30. PubMed ID: 37939696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor.
    Imai R; Higuchi T; Morimoto M; Koyamada R; Okada S
    Intern Med; 2018 Mar; 57(6):899-901. PubMed ID: 29151538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
    Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
    Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency.
    Lam JR; Schneider JL; Quesenberry CP; Corley DA
    Gastroenterology; 2017 Mar; 152(4):821-829.e1. PubMed ID: 27890768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
    Trinh VQ; Shi C; Ma C
    Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.
    Boban M; Zulj M; Persic V; Medved I; Zekanovic D; Vcev A
    Int J Cardiol; 2016 Sep; 219():277-81. PubMed ID: 27343420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
    Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
    Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
    Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
    Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Acute Gastroenteritis and Continuous Use of Proton Pump Inhibitors During Winter Periods of Highest Circulation of Enteric Viruses.
    Vilcu AM; Sabatte L; Blanchon T; Souty C; Maravic M; Lemaitre M; Steichen O; Hanslik T
    JAMA Netw Open; 2019 Nov; 2(11):e1916205. PubMed ID: 31774521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.